Innoviva Inc (NAS:INVA)
$ 19.93 0.49 (2.52%) Market Cap: 1.25 Bil Enterprise Value: 1.45 Bil PE Ratio: 12.07 PB Ratio: 1.87 GF Score: 88/100

Innoviva Inc at Goldman Sachs Healthcare Conference Transcript

Jun 12, 2023 / 09:00PM GMT
Release Date Price: $13.4 (+0.75%)
Unidentified Analyst

Welcome to the afternoon session of the Goldman Sachs Healthcare Conference. We are very pleased to have on stage with us Innoviva with CEO, Pavel Raifeld. I'm joined by my colleague, Roger Xu, who is here and will -- does all the hard work for our team and basically on Innoviva, and we will get a sense for a unique company that I think a lot of folks probably don't know about much about. So I'll ask all the big picture questions, while Roger, who does a lot of work thinking about sort of the details of what's happening in the trenches with kind of the strategic changes there.

Questions & Answers

Unidentified Analyst

So Pavel, to begin with, just maybe just give us a snapshot of Innoviva. In particular, I think it's really interesting in terms of the recent history is like, where did you guys come from? And what are you now? Because there is a subsequent after thought in terms of -- follow-through in terms of and where are you going? So maybe start from the beginning.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot